Human glutathione S-transferase P1-1 (GSTP1-1) is an ubiquitously expressed protein that plays an important role in the detoxification and xenobiotics metabolism. It has been shown that GSTP1-1 interacts with c-Jun NH 2 -terminal kinase (JNK) and suppresses its activity. Here, we report a novel function of GSTP1-1 in regulating tumor necrosis factor-a (TNF-a)-triggered signaling. The present experiments showed that GSTP1-1 physically associated with tumor necrosis factor receptor-associated factor 2 (TRAF2) in vivo and in vitro. Overexpression of GSTP1-1 inhibited TRAF2-induced activation of both JNK and p38 but not of nuclear factor-jB (NF-jB). Glutathione S-transferase P1-1 also attenuated TRAF2-enhanced apoptosis signal-regulating kinase 1 (ASK1) autophosphorylation and inhibited TRAF2-ASK1-induced cell apoptosis by suppressing the interaction of TRAF2 and ASK1. Conversely, silencing of GSTP1-1 expression through RNA interference (RNAi) resulted in increase of TNF-a-dependent TRAF2-ASK1 association followed by hyper-activation of ASK1 and JNK. A mutant GSTP1-1 lacking TRAF domain-binding motif exhibited a significant decline of capacity to bind TRAF2 and block TRAF2-ASK1 signaling compared with the wild type of GSTP1-1. Moreover, the glutathione-conjugating activity of GSTP1-1 was not involved in the regulation of TRAF2 signaling. These findings indicate that GSTP1-1 plays an important regulatory role in TNF-a-induced signaling by forming ligand-binding interactions with TRAF2, which provides a new insight for analysing the protective effects of GSTP1-1 in tumor cells.
Introduction
Tumor necrosis factor-a (TNF-a) is a pleiotropic cytokine that elicits a wide spectrum of physiological and pathogenic events including cell proliferation, differentiation and apoptosis (Arch and Thompson, 1999; Locksley et al., 2001) . TNF-a triggers the activation of the transcription factors, such as activator protein 1 (AP-1) and nuclear factor-kB (NF-kB), through stimulating protein kinase cascades including c-Jun NH 2 -terminal kinases (JNKs)/stress-activated protein kinases (SAPKs) and IkB kinases pathways (Feldmann and Maini, 2001 ). These cellular responses to TNF-a is signaled through two different cell surface receptors, p55 TNF-R1 and p75 TNF-R2 (Tartaglia and Goeddel, 1992) . TNF-a induces homotypic aggregation of these receptors, resulting in the recruitment of a number of adaptor proteins to the cytoplasmic aminoterminal domains of the clustered receptors and consequent initiation of signal transduction (Smith et al., 1994; Ashkenazi and Dixit, 1998; Wajant et al., 2003) .
Tumor necrosis factor receptor-associated factor 2 (TRAF2) is a prototypical member of the TRAF family, which act as important signal transducers for the TNF receptor (TNF-R) and the interleukin-1 receptor/Tolllike receptor superfamily members. To date, seven members of the TRAF family have been identified (TRAF1-7) (Arch et al., 1998; Baud et al., 1999; Bradley and Pober, 2001; Chung et al., 2002; Xu et al., 2004) . TRAF2 mediates TNF-a-induced activation of AP-1 and NF-kB by directly associating with TNF-R2 (Rothe et al., 1994 (Rothe et al., , 1995 and/or recruiting to TNF-R1 through interacting with TNF-R1-associated death domain protein (TRADD) (Hsu et al., 1995 (Hsu et al., , 1996a . It has been well demonstrated that TRAF2 is crucial for downstream signaling events in response to TNF-a, and controls cell growth or death (Xia and Chen, 2005) . Previous overexpression experiments revealed that TRAF2 plays an important role in TNF-a-triggered activation of JNK and NF-kB signaling pathways (Takeuchi et al., 1996; Natoli et al., 1997; Reinhard et al., 1997; Song et al., 1997) . The lack of TRAF2 or the expression of a dominant-negative form of TRAF2 only led to a modest defect in TNF-a-induced NF-kB activation, but resulted in a severe reduction of JNK activation (Lee et al., 1997; Yeh et al., 1997) . However, the precise mechanism by which TRAF2 is capable of mediating these signaling pathways remains largely exclusive.
Mitogen-activated protein kinases (MAPKs) cascades are pivotal components in TRAF2-elicited signal pathways (Ichijo 1999; Davis 2000; Chang and Karin, 2001) . Two major MAPKs , JNK and p38, are known to be activated by TRAF2 and act as the major primary activators of AP-1. TRAF2 interacts directly or indirectly with several MAPK kinase kinases (MAPKKKs) such as apoptosis signal-regulating kinase 1 (ASK1), germinal center kinase and MEK kinase 1 (MEKK1), and thereby activates MAPKs cascades Yuasa et al., 1998; Baud et al., 1999; Hoeflich et al., 1999) .
ASK1 is a MAPKKK that activates both MKK4/7-JNK and MKK3/6-p38 signaling pathways. TNF-a and some oxidative stressors have been reported to activate ASK1 and then to induce cell apoptosis (Ichijo et al., 1997; Gotoh and Copper, 1998; Liu et al., 2000) . Depending on its TRAF domain and RING-finger motif, TRAF2 could enhance ASK1 homo-oligomerization and autophosphorylation at Thr845 by direct protein-protein interaction with ASK1. It has been documented that ASK1 is specifically required for TNFa-and TRAF2-induced sustained JNK and p38 activation. TNF-a or TRAF2 overexpression stimulates production of reactive oxygen species (ROS) that in turn activates ASK1-MKKs-JNK/p38 signal pathways through eliciting TRAF2-ASK1 interaction in target cells Hoeflich et al., 1999; Liu et al., 2000; Tobiume et al., 2002) . Some redoxsensing proteins including thioredoxin (Trx), heat-shock protein 72 (HSP72) and 90 (HSP90) and glutathione S-transferase (GST) Mu (GSTM1-1) Cho et al., 2001; Park et al., 2002; Zhang et al., 2005) could bind ASK1 and inhibit its activity. TRAF2-induced ASK1 activation is likely to be owing to prior dissociation of Trx, a major endogenous inhibitor of ASK1, from ASK1. These findings imply that the free radical scavengers play a crucial role in regulating TRAF2-ASK1 signals Liu et al., 2000) .
The GSTs are identified as a multigene family of isozymes that catalyse the nucleophilic attack of the sulfur atom of glutathione (GSH) on electrophilic groups of substrate molecules (Tew, 1994) . On the basis of the amino-acid sequence, the mammalian GSTs are divided into six classes: a, m, o, p, y and z (Townsend and Tew, 2003a) . Among this family of isozymes, glutathione S-transferase P1-1 (GSTP1-1, GSTp) is the most prevalent isozyme in mammalian cells. Previous studies show that GSTP1-1 is determinant in cellular response to oxidative stress and protects tumor cells from apoptosis elicited by a variety of cytotoxic agents, such as H 2 O 2 , UV, cisplatin and arsenic trioxide (Gate and Tew, 2001; Gilot et al., 2002; Townsend et al., 2002; Lu et al., 2004; Zhou et al., 2004) . More recently, however, it has been shown that GSTs appear to regulate MAPKs via their non-catalytic, ligand-binding activity. GSTP1-1 functions as an endogenous inhibitor of JNK, which interact with the C-terminal of that kinase (Adler et al., 1999; Yin et al., 2000; Wang et al., 2001) . GSTM1-1 (GSTm), another member of GST superfamily, has been identified as a negative regulator of ASK1 and MEKK1 (Cho et al., 2001; Dorion et al., 2002; Ryoo et al., 2004) . Our previous study also showed that GSTP1-1 repressed ROS-induced ASK1 activation in a dose-dependent manner (Yin et al., 2001) .
For more than a decade, GSTP1-1 has generated interest as a neoplastic marker based on its elevated expression in many tumor tissues relative to matched normal tissue (Shea et al., 1988; Moscow et al., 1989) . Recently, elevated expression of GSTP1-1 has been implicated in resistance to apoptosis initiated by a variety of stimuli (Voehringer et al., 2000; Cumming et al., 2001) . However, little is known about the effects of GSTP1-1 on TNF-a-triggered MAPKs activation and apoptotic cell death, particularly it is still unclear whether and how GSTP1-1 regulates TNF-a-activated ASK1-JNK signaling pathway. Here, we show that GSTP1-1 blocks TRAF2-ASK1 interaction and TRAF2-induced ASK1 activation via binding the TRAF domain of TRAF2, and consequently suppresses TNF-a-and TRAF2-ASK1-triggered cell death. These data revealed a novel function of GSTP1-1 in modulating TNF-a/TRAF2-elicited ASK1 activation.
Results

GSTP1-1 inhibits TNF-a-induced ASK1-JNK cascade activation
In order to determine whether TNF-a-induced ASK1-JNK cascade activation could be regulated by GSTP1-1, human cervical carcinoma HeLa cells were transiently transfected with hemagglutinin (HA)-tagged GSTP1-1 or empty vector, followed by treatment with TNF-a (50 ng/ml) for 30 min. The endogenous phosphorylated form of JNKs, MKK4 and ASK1 were determined by immunoblotting using phospho-specific antibodies against JNK/SAPK (Thr183/Tyr185), MKK4 (Ser257/ Thr261) and ASK1 (Thr845), respectively. The results showed that TNF-a-activated ASK1-JNK cascade was markedly reduced in GSTP1-1 overexpressed cells (Figure 1 ). The activation of p38, another important MAPK, induced by TNF-a was also impaired by GSTP1-1-overexpression, but TNF-a-induced degradation of cellular IkBa was not affected (Figure 1 ). Similar results have been obtained from human lymphoma U937 cells (data not shown). These data suggested that, in addition to binding JNK and suppressing its kinase activity, GSTP1-1 might also target on upstream molecule(s) involved in TNF-a-activated MAPK signaling pathways.
GSTP1-1 physically interacts with TRAF2
Glutathione S-transferases have been shown to act as endogenous negative regulators of the JNK signaling GSTP1-1 modulates TNF-a signaling Y Wu et al pathways through binding different kinases, which is revealed by the effects of GSTM1-1 on ASK1 and MEKK1, whereas GSTP1-1 on JNK (Adler et al., 1999; Cho et al., 2001; Ryoo et al., 2004) . Our previous studies indicated that overexpression of GSTP1-1 suppresses ROS-induced activation of ASK1 and MKK7 as well as JNK activation (Yin et al., 2000 (Yin et al., , 2001 . Furthermore, as showed in Figure 1 , GSTP1-1 could also attenuate TNF-a-stimulated activation of p38 and JNK upstream kinases, such as ASK1 and MKK4. Therefore, we next probed whether GSTP1-1 could directly interact with the upstream molecules of MAPKs to exert its inhibitory effects in TNF-a-triggered signals. HeLa cells were treated with TNF-a or left untreated, and then the endogenous JNK1 and p38a were immunoprecipitated with respective antibodies. The immunopellets were analysed by immunoblotting with anti-GSTP1-1 monoclonal antibody. The results showed that GSTP1-1 associated with JNK1 in unstimulated cells, but the binding of GSTP1-1-JNK1 decreased in response to TNF-a stimulus and returned to the basal level thereafter. A weak interaction between GSTP1-1 and p38a, which was not affected by TNF-a, was also observed (Figure 2a, top two panels, lanes 1-8) . However, the bindings of GSTP1-1 with MKK4 or MKK6, the two upstream MAPKKs of JNKs and p38, were not detected in the same experimental conditions (Figure 2a , top two panels, lanes 9-16).
Previous studies have revealed that GSTM1-1, another member of GST superfamily, could associate with ASK1 and MEKK1 directly and inhibit their kinase activities. As these two kinases are the most important MAPKKKs in the TNF-a-activated signaling cascades, we speculated that GSTP1-1 might also target on them directly as GSTM1-1. Unfortunately, no obvious interaction between GSTP1-1 and ASK1 or MEKK1 was found in our experiments ( Figure 2a , middle two panels, lanes 1-8). We then focused on the effects of GSTP1-1 on upstream molecule(s) of ASK1. Two TRAF family proteins, TRAF2 and TRAF6, have been demonstrated to bind to and thereby activate ASK1. Gene-knockout experiments showed that TRAF2 was essential for TNF-a-stimulated ASK1-JNK activation (Lee et al., 1997; Nishitoh et al., 1998; Noguchi et al., 2005) , and TRAF6-ASK1 axis is selectively required for lipopolysaccharide (LPS)-induced activation of p38 . To explore the possibility that TRAF2 or TRAF6 was related with the inhibitory effect of GSTP1-1 on TNF-a triggered ASK1-JNK signaling cascade, endogenous TRAF2 and TRAF6 in HeLa cells were immunoprecipitated with respective antibodies. The results from immunoblot analysis using anti-GSTP1-1 antibody of the TRAF2 or TRAF6 immunoprecipitates revealed that GSTP1-1 specifically associated with TRAF2, but not TRAF6 (Figure 2a , middle two panels, lane 9-16).
The interaction of GSTP1-1 with TRAF2 was next investigated in human embryonic kidney (HEK) 293 cells under overexpression conditions. HEK293 cells were co-transfected with HA-tagged GSTP1-1 and Flagtagged TRAF2 expression vectors or empty vector, respectively, and then the cell lysates were subjected to immunoprecipitation with anti-Flag M2 affinity gels. The results of immunoblot analysis using anti-HA antibody showed that GSTP1-1 significantly associated with TRAF2 (Figure 2b ). Further reciprocal experiments that were carried out by immunoprecipitating HA-GSTP1-1 from transfected HEK293 cell lysates using anti-HA antibody also demonstrated that Flag-TRAF2 but not Flag-TRAF6 specifically associated with GSTP1-1 (Figure 2c ). Moreover, in vitro pull-down assay using bacteria expressed recombinant His-GSTP1-1 and the HEK293 cell lysates containing Flag-tagged TRAF2 or TRAF6 showed the same result (Figure 2d ). Taken together, these results strongly demonstrated that GSTP1-1 physically associated with TRAF2 in mammalian cells. After 30 h, the transfected cells were treated with ( þ ) or without (À) TNF-a (50 ng/ml) for 30 min. Cell lysates were subjected to immunoblot (IB) analysis with anti-phospho-JNK (Thr183/Tyr185), anti-phospho-MKK4 (Ser257/Thr261), anti-phospho-ASK1 (Thr845), anti-IkB, anti-GSTP1-1 and control antibodies as indicated. Phosphorylation of kinases was determined. Relative kinases phosphorylation fold is shown as mean of duplicates from three independent experiments, with untreated as 1.0.
Effects of TNF-a and glutathione on the interaction of TRAF2 with GSTP1-1 In order to further analyse the effects of GSTP1-1 and TRAF2 interaction on TNF-a-triggered signal cascades, we determined whether TNF-a stimulus could alter the binding of GSTP1-1 and TRAF2 that existed in unstressed cells. HeLa cells were treated with TNF-a (50 ng/ml) for different time intervals as indicated and subjected to co-immunoprecipitation and immunoblotting assay. The results showed that the amount of endogenous TRAF2-GSTP1-1 complex decreased to minimum 45 min after TNF-a treatment, and then returned to the basal level at 90 min (Figure 3a) , whereas the GSTP1-1 protein level did not change within this period. In fact, GSTP1-1 level was constant under the TNF-a treatment up to 10 h and not affected by the presence of cycloheximide (CHX), a protein synthesis inhibitor ( Figure 3b ). Therefore, these results indicated that TNF-a stimulation could change the interaction of GSTP1-1 and TRAF2 without altering GSTP1-1 protein level.
As GSTP1-1 is an enzyme that catalysed the conjugation of reduced glutathione to a variety of electrophiles, we also tested whether the intracellular glutathione concentration could influence the interaction between GSTP1-1 and TRAF2 by treating the HeLa cells with N-acetyl-L-cysteine (NAC), an aminothiol and synthetic precursor of intracellular glutathione, or buthionine-(S,R)-sulfoximine (BSO), an inhibitor of GSH synthesis. The data showed that the Lysates from HeLa cells treated with TNF-a (50 ng/ml) were subjected to immunoprecipitation (IP) using indicated antibodies (anti-JNK1, anti-p38a, anti-MKK4, anti-MKK6, anti-ASK1, anti-MEK kinase 1, anti-TRAF2 and anti-TRAF6, 0.5 mg each) or control normal immunoglobulin G (IgG). The precipitates were analysed by immunoblotting with GSTP1-1 monoclonal antibody and corresponding antibodies. The total amounts of GSTP1-1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the whole-cell lysates were determined by immunoblot analysis (bottom panel). (b) HEK293 cells were cotransfected with hemagglutinin (HA)-tagged GSTP1-1 (1 mg) and Flag-tagged TRAF2 (0.5 mg) or empty expression vectors as indicated. After 36 h, the cell lysates (500 mg) were immunoprecipitated with Ezview TM red anti-Flag M2 affinity gel (5 ml), followed by immunoblot analysis with anti-HA antibody or anti-TRAF2 antibody, and the whole-cell lysates were also immunoanalysed with anti-HA antibody. (c) HEK293 cells were co-transfected with HA-GSTP1-1 (0.5 mg, lanes 2 and 3), Flag-TRAF2 (1 mg, lane 2) and Flag-TRAF6 (1 mg, lane 3) as indicated. The whole-cell lysates were subjected to immunoprecipitation using anti-HA antibody and analysed by immunoblotting with anti-Flag antibody to verify the coprecipitated Flag-TRAF2 or Flag-TRAF6. The presence of overexpressed exogenous proteins in the same lysates was verified by immunoblotting. 
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The TRAF domain of TRAF2 mediates GSTP1-1 binding As TRAF2 has no intrinsic catalytic activity, proteinprotein interactions are essential for regulating TRAF2-mediated cellular signaling pathways (Chung et al., 2002) . TRAF2 is an adaptor protein with several domains (Figure 4a ) including the RING-finger and zinc-finger motifs for mediating downstream signaling events and the TRAF domain for interacting with upstream receptors and other signaling molecules, such as ASK1 Hoeflich et al., 1999; Liu et al., 2000) . To determine which domain of TRAF2 was responsible for the association with GSTP1-1, different Flag-tagged TRAF2 deletion mutants and HA-tagged GSTP1-1 were co-transfected into HEK293 cells.
Immunoblot analysis of co-immunoprecipitation assay using anti-Flag M2 affinity gels showed that the TRAF domain amino acids (aa 272-501) but not the RINGfinger (aa 1-87) or zinc-finger motif (aa 87-271) of TRAF2 was required for the interaction of TRAF2 with GSTP1-1 (Figure 4b ).
GSTP1-1 inhibits TRAF2-activated JNK and p38, but not NF-kB
Above data indicated that GSTP1-1 associated with TRAF2 and played a regulatory role in TNF-aactivated signaling cascades. As TRAF2 mediates TNF-a-induced downstream signal pathways including JNK and NF-kB, the role of GSTP1-1 in regulating HA-tagged GSTP1-1 was transiently co-transfected into HEK293 cells with expression plasmids for Flag-tagged wild-type and deletion mutant TRAF2. After 36 h, cell lysates (1 mg) were subjected to immunoprecipitation with Ezview TM red anti-Flag M2 affinity gel (10 ml). Co-precipitated HA-GSTP1-1 was detected by immunoblot analysis with anti-HA antibody. Expression of GSTP1-1 and TRAF2 wild-type and deletion proteins was determined by immunoblotting with anti-HA or anti-Flag antibodies.
GSTP1-1 modulates TNF-a signaling Y Wu et al TRAF2-mediated JNK and NF-kB activation were addressed in transfection studies using Jun2-luciferase or NF-kB-luciferase reporters. HeLa cells were cotransfected with reporter constructs and expression vectors as indicated (Figure 5a and b) . At 36 h after transfection, the cells were treated with TNF-a for 4 h or left untreated, and the luciferase activities were assayed. Without TNF-a, forced expression of TRAF2 alone was sufficient to stimulate JNK and NF-kB activation in transfected cells. Overexpression of GSTP1-1 suppressed TRAF2 or TNF-a-mediated c-Jun activity in a dose-dependent manner, but did not alter the expression of the NF-kB-luciferase reporter in either the presence or absence of TNF-a (Figure 5a ). In comparison, GSTP1-1 did not obviously inhibit the interleukin-1-b (IL-1b) and TRAF6-mediated activation of either c-Jun or NF-kB in the same conditions (Figure 5b) .
We next observed the effects of GSTP1-1 on regulating TRAF2-elicited downstream kinases activation. HeLa cells were transiently cotransfected with expression vectors encoding TRAF2 and/or GSTP1-1 together with JNK1, p38a or MKK7. Exogenous kinases were immunoprecipitated with corresponding antibodies as indicated. Immunoblot analysis using phospho-specific antibodies revealed that forced expression of TRAF2 obviously activated JNK1, p38a and MKK7, and this activation was significantly reduced by the co-expression of GSTP1-1 (Figure 5c -e). These data verified the effects of GSTP1-1 previously described in Figure 1 , and strongly suggested that GSTP1-1 inhibited both TNF-a-and TRAF2-mediated MAPKs but not NF-kB activation via interacted with TRAF2.
GSTP1-1 regulates TRAF2-induced ASK1 activation
It has been well documented that TNF-a-induced TRAF2-ASK1 complex is required for ASK1 activation Liu et al., 2000; Noguchi et al., 2005) . We and another group also found that GSTP1-1 inhibited the enzymatic activity of ASK1 in vivo (Yin et al., 2001) but not in vitro (Cho et al., 2001) . In the present study, GSTP1-1 was found to interact directly with TRAF2 but not ASK1 (Figure 2 ), and repressed TNF-a-induced ASK1 activation (Figure 1 ). Furthermore, both GSTP1-1 and ASK1 were associated with the TRAF domain of TRAF2. All of these findings suggested a possible mechanism that, through binding to Figure 5 GSTP1-1 suppresses TRAF2-induced activation of JNK and p38, but not of NF-kB. (a) Expression vectors for TRAF2 and GSTP1-1 were transfected into HeLa cells together with 5 Â Jun2-Luc or 2 Â NF-kB-Luc reporter plasmid as indicated. After 36 h, cells were left untreated (white) or treated with TNF-a (50 ng/ml) for 4 h (black), and then the luciferase activities were measured using a luciferase assay system and values were normalized based on b-gal activities. Values shown are averages (mean7s.d.) of one representative experiment in which each transfection was performed in triplicate. (b) The transfection experiments were carried out as in (a), expect that TRAF6 plasmid was co-transfected together in lieu of TRAF2, then the cells were treated with (gray) or without (white) interleukin-1-b (10 ng/ml) for 6 h. Relative luciferase activities were determined as described in (a). (c-e) HeLa cells were cotransfected with the indicated combinations of expressing vectors encoding GSTP1-1 (1.5 mg), TRAF2 (1.5 mg), and HA-tagged JNK1 (2 mg) (c), Flag-tagged p38a (2 mg) (d), or Xpress-tagged MKK7 (3 mg) (e). Cells were harvested 36 h after transfection and lysates were subjected to immunoprecipitation with anti-HA, anti-Flag or anti-Xpress antibody. The immunopellets were analysed by immunoblotting with anti-phospho-JNK (Thr183/Tyr185) (c), anti-phospho-p38 (Thr180/Tyr182) (d), or anti-phospho-MKK7 (Ser271/Thr275) (e) antibody, respectively. The overexpressed exogenous proteins were detected using corresponding antibodies. Relative kinases phosphorylation fold is shown as mean of duplicates from three independent experiments.
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Y Wu et al TRAF2, GSTP1-1 blocked TRAF2-ASK1 complex information, and subsequent ASK1 activation. Therefore, the effect of GSTP1-1 on the TRAF2-induced ASK1 autophosphorylation and kinase catalytic activity was first investigated in overexpression conditions. HEK293 cells were co-transfected with the indicated combinations of expression vectors producing HA-ASK1 (0.1 mg), Flag-TRAF2 (2 mg) and Xpress-GSTP1-1 (1 mg), and then HA-ASK1 was immunoprecipitated. Immunoblot analysis using phospho-specific antibody against ASK1 (Thr845) showed that ASK1 phosphorylation at Thr845 stimulated by TRAF2 was apparently inhibited by co-expression of GSTP1-1 (Figure 6a ). As expected, the kinase catalytic activity of HA-ASK1 (measured using an in vitro kinase assay with His-MKK7 as a substrate) induced by forced expressed TRAF2 was inhibited by GSTP1-1 in a dosedependent manner (Figure 6b ). In addition, co-immunoprecipitation study showed that overexpression of GSTP1-1 blocked the physical association of exogenous expressed TRAF2 with ASK1 ( Figure 6c ). Similar to that in HeLa cells (Figure 2 ), we also failed to find the GSTP1-1-ASK1 complex in co-transfected HEK293 cells.
To confirm that GSTP1-1 counteract ASK1 activation during TNF-a stimulation through inhibition of endogenous TRAF2-ASK1 interaction, GSTP1-1 protein expression was silenced using HP validated Small interfering RNA (siRNA) targeted against human GSTP1-1 (siGSTP1-1) (Qiagen GmbH, Hilden, Germany). The successful knockdown of the GSTP1-1 gene was exhibited by the specific reduction of the GSTP1-1 expression in siGSTP1-1 but not RNAiFect TM alone or non-silencing siRNA (siNS)-transfected HeLa cells (Figure 7a ). We thus tested the effect of GSTP1-1 silencing on TNF-a-induced ASK1 and JNK activation.
HeLa cells were transfected with either siNS (Figure 7b , lanes 1-12) or siGSTP1-1 (Figure 7b, lanes 13-18) . After 36 h, the cells were transfected again with the same amount of siRNA together with HA-tagged GSTP1-1 expression vector (Figure 7b, lanes 7-12) or empty vector (Figure 7b, lanes 1-6 and 13-18) . At 30 h following the second transfection, the cells were treated with TNF-a (50 ng/ml) for the indicated times. Endogenous TRAF2 of different samples were immunoprecipitated with anti-TRAF2 antibody, followed by immunoblot analysis. TRAF2 interacted with ASK1 at Figure 6 GSTP1-1 inhibits TRAF2-induced ASK1 catalytic activity. (a) HEK293 cells were co-transfected with the indicated combinations of expression vectors producing HA-ASK1 (0.1 mg), Flag-TRAF2 (2 mg) and Xpress-GSTP1-1 (1 mg). The cell lysates (1 mg) were immunoprecipitated with anti-HA antibody (0.5 mg), and the immunopellets were detected by immunoblot analysis with anti-phospho-ASK1 (Thr845) antibody. (b) HEK293 cells were transiently co-transfected with HA-tagged ASK1 (1 mg), Flagtagged TRAF2 (1.5 mg) and Xpress-tagged GSTP1-1 (0.5, 1.0 and 1.5 mg) as indicated. After 36 h, the HA-tagged ASK1 were immunoprecipitated with anti-HA antibody (0.5 mg) from 200 mg of whole-cell lysates, and their kinase activities (KA) were assessed using His-MKK7 (K149M) as substrate. Equal amount of HAtagged ASK1 used in each assay were confirmed by immunoblotting. Data shown are the representative of three independent experiments. The fold activation relative to that of cells cotransfected with an empty vector and an expression vector encoding HA-tagged ASK1 is the average of the three experiments. (c) HEK293 cells were co-transfected with Xpress-tagged GSTP1-1 (1 mg), Flag-tagged TRAF2 (1.5 mg) and HA-tagged ASK1 (1 mg) as indicated. After 36 h, the cells lysates (600 mg) were immunoprecipitated with Ezview TM red anti-Flag M2 affinity gel or anti-Xpress antibody (0.5 mg), and the immunopellets were analysed by immunoblot analysis with anti-HA antibodies. Overexpressed ASK1 and GSTP1-1 were detected using anti-HA and anti-Xpress antibodies, respectively. One representative experiment is shown in each panel.
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15 min after TNF-a stimulating in control cells (Figure 7b, panel 1, lanes 1-6) . Overexpression of GSTP1-1 repressed the amount of TNF-a-induced TRAF2-ASK1 complex (Figure 7b , panel 1, lanes 7-12). In comparison, marked enhancement of TRAF2-ASK1 interaction was observed in GSTP1-1 knockdown cells (Figure 7b, panel 1, lanes 13-18) . As the consequence of TRAF2 and ASK1 association, ASK1 and JNK activation also dramatically increased and sustained by the GSTP1-1-knockdown (Figure 7b,  panel 4 and 5, lanes 13-18) . However, the interaction between TRAF2 and MEKK1, another important MAPKKK (Baud et al., 1999) , was not affected by the GSTP1-1 expression level (Figure 7b, panel 7 ). In the above experiments, the amounts of ASK1, MEKK1 as well as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins used as the control were comparable in the different samples.
As TRAF2-ASK1 axis is essential for mediating TNF-a and oxidative stresses stimulated apoptotic cell death (Tobiume et al., 2001; Noguchi et al., 2005) , we also determined the effect of GSTP1-1 on TNF-ainduced HeLa cell apoptosis by microscopy ( Figure 7c ) and flow cytometry using propidium iodide (PI) staining (Figure 7d) . Exposure of GSTP1-1-knockdown HeLa cells to TNF-a plus CHX markedly enhanced apoptotic cell death. On the other hand, overexpression of GSTP1-1 alleviated apoptosis of transfected HeLa cells to the same extent as ASK1 (K709R), a catalytically inactive form of ASK1 (Figure 7c and d) . Moreover, pretreating the cells with NAC reversed the enhancement of TNF-a-induced cell death in GSTP1-1 knockdown cells. These results indicated that cellular GSTP1-1 indeed played an important role in regulating TNF-atriggered TRAF2-ASK1 association and was a survival factor for protecting cells against TRAF2-ASK1 axisdependent apoptosis.
A TRAF2-binding motif, TWQE from GSTP1-1, is responsive for the interaction of TRAF2 with GSTP1-1 Structural studies of TRAF2-binding proteins revealed a major consensus motif, (P/S/A/T)x(Q/E)E, and a minor consensus motif, PxQxxD Ye et al., 1999; Ye and Wu, 2000) . In the GSTP1-1 sequence, a potent TRAF2-binding motif TWQE (aa 38-41) was found. To evaluate the importance of this motif for TRAF2-binding, we generated a mutant of GSTP1-1, GSTP1-1 (TWAL), in which the Gln-40 and Glu-41 that did not affect the enzyme activity of GSTP1-1 in vitro (data not shown) were mutated with Ala and Leu, respectively (Figure 8a ). GSTP1-1 (TWAL) mutant displayed an obvious decreased affinity to bind TRAF2 in immunoprecipitation experiments, which indicated that the TRAF2-binding motif of GSTP1-1 is important for GSTP1-1-TRAF2 association. In comparison, another GSTP1-1 mutant, GSTP1-1 (Y7F), whose catalytic activity was blocked by replacing a tyrosine with phenylalanine in the seventh amino-terminal position acted as effective as GSTP1-1 (WT) in binding to TRAF2 (Figure 8b ). In vitro pull-down assay also showed the similar results (Figure 8c) .
In comparing the regulatory effects of the different GSTP1-1 proteins on TRAF2-induced ASK1-JNK cascade using luciferase reporter system, we found that the transcriptional activity of c-Jun was dramatically suppressed by GSTP1-1 (WT) and GSTP1-1(Y7F), but was only slightly inhibited by GSTP1-1 (TWAL) (Figure 8d) . Furthermore, the GSTP1-1 (TWAL) revealed no ability to block TRAF2-induced ASK1 catalytic activity compared with GSTP1-1 (WT) and GSTP1-1 (Y7F) (Figure 8e ).
Forced expression of high levels of TRAF2 and ASK1 could make the HEK293 cells shrink, detach and float, which, together with the results of previous study (Hoeflich et al., 1999) , suggested that TRAF2 not only mediated cell survival pathways but also led to programmed cell death by interacting with ASK1. The result from flow cytometry showed that TRAF2 and ASK1 co-expression elicited apoptotic cell death and such cell apoptosis were inhibited by co-expression GSTP1-1 (WT) or GSTP1-1 (Y7F) but only partially suppressed by GSTP1-1 (TWAL) (Figure 8f ), corresponding to the effects of GSTP1-1 and its mutants on inhibition of TRAF2-induced ASK1 kinase activity (Figure 8e ). These results showed that the TRAF2-binding function rather than GSH-conjugating catalytic activity of GSTP1-1 is critical for its regulatory effects on TRAF2-ASK1 signaling cascade.
Discussion
Glutathione S-transferases are members of a phase IImetabolizing enzymes superfamily, which play an important role in detoxification of ROS and maintenance of the cellular redox state. Although GSTs were early investigated because of their enzymatic activity involved in the conjugation of GSH to a wide range of electrophilic metabolites and effects on protecting tumor cells against toxic drugs and oxidative stress, they were then discovered as 'ligandins' owing to their abilities to interact covalently and non-covalently with various compounds that were not substrates for enzymatic activity, including steroids, thyroid hormones, bilirubin, prostaglandins and bile acid (Townsend and Tew, 2003a, b) . As the ligand-binding characters of GSTs were confirmed, the regulatory effects of GSTs on stressactivated cellular signal pathway were revealed in various experiments.
Recent reports showed that GSTs functioned to sequester MAPKs and acted as negative regulators, but the mechanisms of these regulations were different. Although both GSTP1-1 and GSTM1-1 protect cells from death elicited by various stresses (H 2 O 2 , UV, serum depletion, etc.) through inhibiting JNK signaltransduction pathway, GSTP1-1 associated with JNK to keep its basal activity low in non-stressed cells (Adler et al., 1999) , whereas GSTM1-1 interacted with ASK1 and MEKK1 directly and repressed ASK1-and MEKK1-dependent apoptotic cell death (Cho et al., 2001; Ryoo et al., 2004) . GSTP1-1 inhibits 13-18) . After 36 h, the cells were transfected again with the same amount of siRNA together with HA tagged GSTP1-1 expression vector (lanes 7-12) or empty vector (lanes 1-6 and 13-18). At 36 h after the second transfection, the cells were treated with TNF-a (50 ng/ml) for the indicated periods. Cell lysates were subjected to immunoblot analysis with anti-phospho-JNK (Thr183/ Tyr185) and anti-phospho-ASK1 (Thr845) antibodies. The same lysates were immunoprecipitated with anti-TRAF2 antibody followed by immunoblot analysed with anti-ASK1 or anti-MEK kinase 1 antibodies. The efficiency of GSTP1-1 overexpression (lanes 7-12) and suppression (lanes 13-18) was determined using anti-GSTP1-1 antibody. (c) The transfected HeLa cells were treated with TNF-a (50 ng/ml) and cycloheximide (CHX, 1 mg/ml) for 12 h. Phase-contrast photography of transfected HeLa cells treated with or without TNF-a/CHX as indicated. (d) The transfected HeLa cells were incubated with 5 mM N-acetyl-L-cysteine (NAC) for 5 h followed by treated with TNF-a/CHX for 12 h. Apoptotic cell death was assessed by flow cytometry as described in Material and methods. The percentage of apoptotic cells are shown as means7s.d. from three independent experiments.
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ROS-stimulated ASK1 activation in vivo (Yin et al., 2001 ), but does not affect the UV-induced ASK1 activity in vitro (Cho et al., 2001; Ryoo et al., 2004) . The present results demonstrated that GSTP1-1 directly associated with TRAF2 but not TRAF6, and subsequently inhibited TRAF2-elicited ASK1-JNK signaling cascade, suggesting that GSTP1-1 might regulate TNFa-activated TRAF2-ASK1 axis and subsequent cell apoptosis by interacting with TRAF2.
TRAF2 is considered to be a central regulator of TNF-a signaling pathway as it acts as an important cellular adaptor protein to mediate ASK1 activation. The role of TRAF2-ASK1 association in TNF-atriggered sustained activation of JNK and p38 has been well documented (Hoeflich et al., 1999; Liu et al., 2000; Tobiume et al., 2001 ). TNF-a-induced production of ROS triggers the dissociation of Trx from ASK1 and consequently liberalizes ASK1 for binding with TRAF2. TRAF2 appears to activate ASK1 by enhancing and stabilizing the oligomerization and autophosphorylation of ASK1. In the present study, both overexpression and RNA interfering experiments demonstrated that GSTP1-1 negatively regulated TNF-a-induced recruitment of ASK1 to TRAF2, while had no effect on the TRAF2-MEKK1 association. GSTP1-1 inhibited sustained activation of ASK1 and JNK, and subsequently protected cells from ASK1-JNK cascade-dependent apoptosis elicited by TNF-a. In addition, unlike GSTM1-1 that targeted on ASK1 and MEKK1, GSTP1-1 acted on JNK and TRAF2 in stress-induced MAPKs activation. The discrepancy of tissue distribution and expression level between GSTM1-1 and GSTP1-1 might account for this difference.
Structural analysis in our experiments characterized the detailed mechanism of the physical and functional interaction between GSTP1-1 and TRAF2. TRAF2 contains a conserved C-terminal homology region termed the TRAF domain, and N-terminal RINGfinger and several zinc-finger motifs. Both the TRAF domain and the RING-finger motif of TRAF2 are required for TRAF2-mediated downstream signals. In TNF-a-activated TRAF2-ASK1-JNK cascade, the TRAF domain is essential for TRAF2-ASK1 association, whereas the RING motif is required for the generation of ROS Hoeflich et al., 1999; Liu et al., 2000) . Furthermore, a consensus major motif (P/S/A/T)x(Q/E)E was reported to exist in the TRAF2-binding proteins including TNFR superfamily members (such as TNFR2, CD40,CD30, OX40, 4-1BB and LMP) and TRAF2-regulated molecules (such as sphingosine kinase and PKN1) (Xia et al., 2002; Gotoh et al., 2004) . The present study showed that the TRAF 
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Y Wu et al domain of TRAF2 and TRAF2-binding motif (TWQE aa 38-41) in GSTP1-1 was necessary for the binding of TRAF2 to GSTP1-1. Glutathione S-transferase P1-1 (TWAL) containing a mutated TRAF2-binding motif (TWQE aa 38-41) not only showed obvious weak binding affinity to TRAF2 compared with GSTP1-1 (WT) but also revealed a limited ability to block TRAF2-induced ASK1 activation and cell apoptosis. It has been reported that endogenous TRAF2 coprecipitated with ASK1 in a TNF-a-dependent manner Hoeflich et al., 1999) . In the present study, we noticed that there is a specific association between GSTP1-1 and TRAF2 but no association of TRAF2 and ASK1 in resting cells, after TNF-a stimulation, the complex of GSTP1-1-TRAF2 obviously decreased, whereas the interaction of TRAF2-ASK1 increased with the kinetics comparable to the dissociation of GSTP1-1 from TRAF2. Taken together, the observation described herein suggests a new regulatory function of GSTP1-1 in TNF-a triggered signal cascades: by competing with ASK1 for binding to the TRAF domain of TRAF2, GSTP1-1 thus inhibits TNF-a-induced TRAF2-ASK1-JNK cascade activation and cell apoptosis. The endogenous GSTP1-1 associates with TRAF2 in unstimulated cells and dissociates from TRAF2 after TNF-a treatment, and subsequently results in the association of ROS-liberated ASK1 with TRAF2 and activation of downstream signaling pathways.
The inhibition effects of GSTP1-1 and GSTM1-1 on ASK1-JNK signaling cascade were independent of their GSH-conjugating activity (Adler et al., 1999; Cho et al., 2001; Ryoo et al., 2004) . The tyrosine residue in the seventh amino-acid position of GSTP1-1 was confirmed to be critical for its enzyme activity (Kong et al., 1992) . Two of our findings that GSTP1-1 (Y7F), an enzymatic inactive mutant, acted as same as GSTP1-1 (WT) in binding TRAF2 and regulating its signaling, and the cellular GSH concentration did not affect the amount of endogenous GSTP1-1-TRAF2 complex indicated that GSTP1-1 enzymatic activity and cellular GSH level did not involve in the 'TRAF2-binding' regulatory function of GSTP1-1. Previous studies suggested that TNF-atriggered TRAF2-ASK1 interaction was dependent on ROS. Some ROS scavengers, such as NAC, inhibited the disassociation of ASK1-Trx and thus suppressed TNF-a-elicited cell apoptosis Liu et al., 2000; Noguchi et al., 2005) . However, our study demonstrated that the interaction of GSTP1-1 and TRAF2 was not influenced by NAC or BSO in resting or TNF-a-treated HeLa cells, and suggested that the mechanism of TNF-a-induced disassociation of TRAF2-GSTP1-1 and ASK1-Trx may be different. We will test this hypothesis in the future studies.
Our recent report showed that GSTP1 could downregulate the LPS-activated signaling pathways, including MAPKs, NF-kB and subsequent cytokine secretion (Xue et al., 2005) . A variety of cytotoxic agents and proinflammatory factors, including LPS, could activate some transcription factors and increase cytosolic GSTP1-1 level, which in turn regulated the stress signaling pathways (Pinkus et al., 1995 (Pinkus et al., , 1996 Fessler et al., 2002; Xue et al., 2005) . However, as described in the present study, GSTP1-1 had no effect on TNF-aand TRAF2-induced NF-kB activation. During the TNF-a treatment, the GSTP1-1 protein level was constant up to 10 h and not affected by the presence of CHX. Furthermore, we did not find interaction of GSTP1-1 and TRAF6 even upon LPS treatment in macrophages (unpublished data). The diverse effects of the GSTP1-1 might be owing to two distinct mechanisms: the 'ROS scavenge' and 'ligand binding', by which GSTP1-1 functions as a regulator in anti-inflammatory and antiapoptosis responses, respectively.
GSTP1-1 regulates TNF-a signaling pathway mainly via protein-protein direct interaction, but there are also some other potential mechanisms involved in this process. GSTP1-1 undergo phosphorylation by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, resulting in a significant enhancement of its metabolic activity (Lo et al., 2004) . Whether GSTP1-1 could be phosphorylated by TNF-a stimulus and phospho-GSTP1-1 could affect proapoptotic cytokine-induced MAPKs signaling cascades remain largely elusive. TNF-a-induced cells apoptosis mainly through two major signaling cascades: ASK1-JNK and TRADD-FADD-caspase-8 pathways (Locksley et al., 2001) . Although NAC obviously reversed the enhancement of TNF-a/CHX-induced cell death in GSTP1-1-knockdown HeLa cells in our experiments, we could not exclude the possibility that GSTP1-1 involves in the latter pathway. The relationship between GSTP1-1 and caspases cascade has never been reported before. Whether GSTP1-1 is involved in death receptormediated caspases activation is under investigation.
In conclusion, the results of the present study elucidate a novel ligand-binding function of GSTP1-1 in regulating kinase signaling and provide a new insight for analysing the mechanism utilized by GSTP1-1 to protect cells against different injury stimulus such as cytokines, UV or H 2 O 2 . Moreover, it is conceivable that GSTP1-1 functions as a general survival factor by forming GSTP1-1-TRAF2 complex in tumor cells. Thus, inhibition of this complex may provide a novel strategy for antitumor therapy.
Materials and methods
DNA constructs
pcDNA3-HA-GSTP1-1 has been described previously (Adler et al., 1999) . pcDNA3.1-His-Xpress-GSTP1-1 was generated from pcDNA3-HA-GSTP1-1 by inserting hGSTP1-1 cDNA into pcDNA3.1-His vector (Invitrogen, Carlsbad, CA, USA). 5 Â Jun2-Luc, 2 Â NF-kB-Luc reporter vector, pcDNA3-HA-ASK1, pCMV-Flag-TRAF2 wild type and other TRAF2 truncated constructs were generous gifts from Dr Ze'ev Ronai (The Burnham Institute, USA). pcDNA3.1-Xpress-MKK7 and pcDNA3.1-Xpress-MKK7 (K149M) expression vectors were kindly provided by Dr Zhenguo Wu (Hong Kong University of Science and Technology). Bacterial expressed MKK7 (K149M) was produced and cloned into pET-28a (Novagen, Madison, WI, USA). pcDNA3.1-Xpress-GSTP1-1 (TWAL) and pcDNA3.1-Xpress-GSTP1-1 (Y7F) were constructed with the QuickChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA). The mutagenic primers (Y7F-F, 5 0 -CACCGTGGTCTTCTTCCCAGTTCG-3 0 ; Y7F-R, 5 0 -CGAACTGGGAAGAAGACCACGGTG-3 0 ; and TWAL-F,
0 -GTGTGAGCCCAGGGCCCACGTCACCACG-3 0 ) were designed to generate GSTP1-1 (Y7F) and GSTP1-1 (TWAL) mutants, respectively. Both expression vectors were sequenced using T7 primer to confirm mutation. GSTP1-1 wild type, Y7F and TWAL mutants were cloned into pET-28a for bacterial expression. All plasmids were purified using the Endofree Plasmid Preparation kit (Qiagen).
Cell culture and transfection HEK 293 cells and cervical carcinoma HeLa cells obtained from Institute of Biochemistry and Cell Biology, the Chinese Academy of Sciences (Shanghai, People's Republic of China), were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (HyClone, Logan, UT, USA), 100 U/ml penicillin and 100 mg/ml streptomycin at 371C with 5% CO 2 . Transient transfection was performed with a modified calcium phosphate method or by the LipofectAMINE 2000 reagent (Invitrogen) according to the manufacturer's instructions. In all cases, the total amount of DNA was normalized by the empty control plasmids.
Antibodies and reagents
Mouse monoclonal antibody against HA-tag and polyclonal antibodies against JNK/SAPK, MKK4, phospho-JNK/SAPK (Thr183/Tyr185), phospho-p38 MAPK (Thr180/Tyr182), phospho-MKK4 (Ser257/Thr261), phospho-MKK7 (Ser271/ Thr275) and phospho-ASK1 (Thr845) were obtained from Cell Signaling Technology (Beverly, MA, USA). Antibodies against MKK6 (N-19), MEKK1 (1-9C-2A), TRAF2 (sc-876), TRAF6 (H-274), IkBa (C-21) and normal mouse, rabbit or goat immunoglobulin G were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal antibody against ASK1 was from Upstate (Lake Placid, NY, USA). Monoclonal antibodies against GSTP1-1, JNK1, p38a, TRAF2 and recombinant human TNF-a were purchased from BD Pharmingen or BD Transduction Laboratories (San Diego, CA, USA). Monoclonal antibody against Xpress-tag was purchased from Invitrogen. Horseradish peroxidase-conjugated secondary antibodies and CHX were obtained from Calbiochem (La Jolla, CA, USA). Recombinant human IL-1b was purchased from Chemicon (Temecula, CA, USA). Anti-Flag M2 monoclonal antibodies, Ezview TM red anti-Flag M2 affinity gel, NAC and BSO were obtained from Sigma (St Louis, MO, USA).
Co-immunoprecipitation and immunoblotting analysis HEK293 or HeLa Cells were lysed in the lysis buffer containing 20 mM Tris (pH7.5), 135 mM NaCl, 2 mM ethylenediaminetetraacetic acid (EDTA), 2 mM dithiothreitol (DTT), 25 mM b-glycerophosphate, 2 mM sodium pyrophosphate, 10% glycerol, 1% Triton X-100, 1 mM sodium orthovanadate, 10 mM NaF and 1 mM phenylmethylsulfonyl fluoride (PMSF) supplemented with complete protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN, USA) at 41C. Lysates were centrifuged (15 000 g) at 41C for 15 min. Proteins (500 mg) were immunoprecipitated with indicated antibodies (0.5 mg), respectively. The precleared Protein A/G PLUSagarose beads (Santa Cruz Biotechnology) were incubated with immunocomplexes for another 2 h and washed four times with the lysis buffer. For Flag-tagged proteins immunoprecipitation, the lysates (500 mg) were incubated with 5 ml Ezview TM red anti-Flag M2 affinity gel for 2 h at 41C. The beads were washed three times using the lysis buffer and then twice using tris-buffered saline buffer. The immunoprecipitates were subjected to SDS-PAGE followed by transferring onto polyvinylidene difluoride Western membranes. The immunoblot analyses were performed as described previously (Adler et al., 1999) . The antibody-antigen complexes were visualized by chemiluminescence method using Lumi-Light Western Blotting Substrate (Roche Applied Science) or using TMB immunoblotting system (Promega, Madison, WI, USA). The total density of the protein bands was calculated using Gel Doc2000 (Bio-Rad, Hercules, CA, USA). Aliquots of wholecell lysates were subjected to immunoblotting analysis to confirm appropriate expression of proteins.
In vitro pull-down binding assays Recombinant polyhistidine-tagged GSTP1-1(WT), GSTP1-1(TWAL) and GSTP1-1(Y7F) proteins were expressed in Escherichia. coli BL21 (DE3) using pET28a vector (Novagen). Lysates of HEK293 cell transfected with Flag-tagged TRAF2 or Flag-tagged TRAF6 were incubated with His-GSTP1-1 immobilized on Ni 2 þ -IDA-agarose beads (Novagen) in the lysis buffer at 41C for 8 h. The proteins of interest were analysed by SDS-PAGE and immunoblotting using anti-Flag M2 antibody.
Measurement of intracellular GSH level
The GSH level were measured as described previously (Fan et al., 2005) using Glutathione Assay kit (Calbiochem).
Luciferase reporter assays
HeLa cells cultured in 12-well plates were transiently transfected with c-Jun or NF-kB target sequence-linkedluciferase reporter plasmid (5 Â Jun2-Luc; 0.2 mg or 2 Â NFkB-Luc; 0.5 mg) together with indicated expression vectors. At 36 h after transfection, cells were treated with TNF-a (50 ng/ ml) for 4 h and protein samples were prepared. The luciferase activity was measured using Luciferase Assay System (Promega) and analysed by the Luminometer TD-20/20 (Turner Co. Ltd., Sunnyvale, CA, USA). pCMV-b-galactosidase (b-gal) expression vector (0.5 mg) was added in each transfection and the b-gal assay was carried out as described previously (Adler et al., 1999) to normalize the transfection efficiency. Each transfection was performed at least twice with triplicates.
In vitro kinase assays
The transfected HEK293 cells were lysed with lysis buffer containing 20 mM Tris (pH 7.5), 135 mM NaCl, 2 mM EDTA, 2 mM DTT, 25 mM b-glycerophosphate, 2 mM sodium pyrophosphate, 10 mM NaF, 10% glycerol, 1% Triton X-100, 1 mM sodium orthovanadate and 1 mM PMSF supplemented with complete protease inhibitor cocktail. After centrifugation, HA-ASK1 was immunoprecipitated with anti-HA monoclonal antibody as described above. The agarose beads were rinsed three times with the lysis buffer and once with the kinase assay buffer containing 25 mM Tris (pH 7.5), 5 mM b-glycerophosphate, 2 mM DTT, 10 mM MgCl 2 and 1 mM sodium orthovanadate. The activity of ASK1 was determined by incubation with bacterial expressed His-MKK7 (K149M) protein as substrate at 301C for 25 min in 50 ml kinase assay buffer supplemented with 100 mM ATP. The reaction was terminated by the addition of Laemmli sample buffer and the proteins were subjected to SDS-PAGE. The phosphorylated His-MKK7 (K149M) was visualized by immunoblotting with phospho-specific polyclonal antibody to MKK7 (Ser271/ Tyr275).
RNA interference
Small interfering RNA specific for human GSTP1-1 and control (non-silencing) siRNA were purchased from Qiagen. (Product name: Hs_GSTP1_1_HP validated siRNA; catalog number: S100300349). The lyophilized siRNAs dissolved in suspension buffer (Qiagen) as 20 mM solutions were heated to 901C for 1 min, followed by annealing at 371C for 60 min. HeLa cells were planted on six-or 96-well plates to 30-50% confluence and were transfected with the RNA oligonucleotides using RNAiFect TM transfection reagent (Qiagen) according to the manufacturer's instructions, resulting in a final RNA concentration of 100 nM. After 36 h, the cells were transfected again with the same amount of siRNA together with expression or empty vectors using LipofectAMINE 2000. At 30 h after the second transfection, the cells were treated with TNF-a (50 ng/ml) for the indicated time and prepared for immunoprecipitation and immunoblot analysis.
Apoptotic cell death assays
HeLa or 293 cells were harvested by trypsinization, centrifuged and resuspended in phosphate-buffered saline. The cells were fixed with 70% ethanol and stained with PI (10 mg/ml) and RNase A (50 mg/ml) and incubated overnight. The cells were analysed on a FACS Vantage SE flow cytometer (Becton Dickinson, San Jose, CA, USA), and the data were analysed using ModFitLT V2.0 DNA modeling software (Versity Software, Topsham, ME, USA).
